Discover our top-rated, regulated brokers. Compare platforms, fees and features, and explore the latest broker offers.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
61% of retail CFD accounts lose money. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong. Take 2 mins to learn more at https://etoro.tw/44JRWLY
CFDs and FX are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
AskTraders may earn a commission when you click through to a broker.
Vietnam has announced plans to boost its purchases of American goods, including defense and security products, in a strategic move to address its considerable trade surplus with the…
Super Micro’s stock (NASDAQ: SMCI) has been in the midst of a wave of volatility, with longer term holders more used to the recent wild swings than most.…
Roku’s stock price (NASDAQ: ROKU) is indicating a pre-market gain of 3.27% this morning, adding to the more than 7% rally from the intraday low into the close…
Chesapeake Utilities Corporation (NYSE: CPK) updated investors on projects that support their 5-year capital expenditure plan, which is projected to range from $1.5 billion to $1.8 billion. This…
Diamondback Energy’s stock (NASDAQ: FANG) saw its rating uplifted from Neutral to Buy by Citi analyst Scott Gruber, sparking a decent boost for the bulls. The pre-market session…
Tesco (LON: TSCO) is set to report its full-year results on Thursday, April 10. Analysts have said in recent notes that they expect steady growth in revenue and…
JP Morgan’s stock price (NYSE: JPM) trades down 3.46% in this morning’s pre-market, as earnings loom towards the end of this week. Analysts have recently updated their forecasts…
Healthcare giant Johnson & Johnson’s stock (NYSE: JNJ) has held up better than most through the recent downturn, with the consumer staples name being seen as a defensive…
In a year marked by significant market instability, Warren Buffett, widely known as the “Oracle of Omaha,” stands out as a rare gainer among the world’s wealthiest individuals.…
Global financial markets continue to experience turbulence as fears over escalating U.S. tariffs sent stocks tumbling and investors risk appetite following suit. This market reaction follows recent trade…
Constellation Brands shares (NYSE: STZ) are down 3% through the early part of pre-market, on top of a YTD decline that has hit 27.18%. The company, a leading…
Shares of major Asian tech stocks sold off heavily to start the week, with major suppliers to Apple Inc. (NASDAQ: AAPL) and NVIDIA Corporation (NASDAQ: NVDA) particularly impacted.…
Barclays analysts recently made a notable change in their outlook for Equifax (NYSE: EFX), downgrading the stock from Overweight to Equal Weight. Equifax’s stock price shed 9.37% on…
International Airlines Group shares (LON: IAG) continued their sharp decline last week, down 11.91% on the week to close at 238p. The stock has now dropped 27% over…
Global financial markets are facing significant challenges as trade tensions between the United States and other major economies escalate. Asian and Australian stock markets have suffered substantial losses…
The announcement of a JV between Intel and TSMC had a marked impact on the stock market yesterday, only for the rally to be swept up in the…
Meta Platforms’ stock price (NASDAQ: META) fell sharply as tariff news broke, down 8.96% on a day that was the worst for markets in 5 years. The company…
AstraZeneca (LON: AZN) announced Friday that it has secured European Union (EU) approval for two of its key cancer drugs, Enhertu and Imfinzi, in separate indications. Enhertu, developed…
CrowdStrike’s stock (NASDAQ: CRWD) was certainly not immune from the downwards market pressure in recent days, seeing the year-to-date gains erased on a 6.49% decline. Returning back to…
On Friday, BP (LON: BP.) announced that its board of directors has begun the process of selecting a new Chair following Helge Lund’s decision to step down. Helge…
Sign up to our free Morning Markets email, every weekday before the open.
Español
Melayu
Deutsch
